Wendy Nembhard
Concepts (369)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 52 | 2025 | 625 | 9.730 |
Why?
| | Congenital Abnormalities | 24 | 2026 | 117 | 6.450 |
Why?
| | Registries | 30 | 2025 | 652 | 3.090 |
Why?
| | Stillbirth | 12 | 2024 | 29 | 2.980 |
Why?
| | Infant, Newborn | 56 | 2026 | 2913 | 2.500 |
Why?
| | Population Surveillance | 17 | 2024 | 164 | 2.480 |
Why?
| | Infant | 59 | 2026 | 3805 | 2.480 |
Why?
| | Pregnancy | 58 | 2026 | 2608 | 2.400 |
Why?
| | Hypospadias | 6 | 2026 | 36 | 2.240 |
Why?
| | Female | 121 | 2026 | 28782 | 2.070 |
Why?
| | Gastroschisis | 7 | 2024 | 38 | 2.000 |
Why?
| | Prevalence | 31 | 2026 | 1034 | 1.900 |
Why?
| | Humans | 146 | 2026 | 53230 | 1.780 |
Why?
| | Environmental Exposure | 5 | 2026 | 222 | 1.750 |
Why?
| | Adult | 61 | 2026 | 14534 | 1.650 |
Why?
| | Genetic Predisposition to Disease | 10 | 2025 | 533 | 1.590 |
Why?
| | United States | 42 | 2026 | 5409 | 1.450 |
Why?
| | Infant Mortality | 8 | 2024 | 65 | 1.440 |
Why?
| | Risk Factors | 38 | 2026 | 4017 | 1.440 |
Why?
| | Child | 42 | 2026 | 7379 | 1.380 |
Why?
| | Case-Control Studies | 27 | 2026 | 1212 | 1.330 |
Why?
| | Male | 74 | 2026 | 27435 | 1.300 |
Why?
| | Young Adult | 31 | 2025 | 4511 | 1.240 |
Why?
| | Maternal Exposure | 10 | 2026 | 103 | 1.230 |
Why?
| | Cesarean Section | 3 | 2021 | 158 | 1.190 |
Why?
| | Occupational Exposure | 3 | 2026 | 106 | 1.190 |
Why?
| | Poultry | 2 | 2026 | 25 | 1.150 |
Why?
| | Arkansas | 14 | 2026 | 2068 | 1.130 |
Why?
| | Retrospective Studies | 34 | 2026 | 6819 | 1.130 |
Why?
| | Child Mortality | 5 | 2020 | 12 | 1.130 |
Why?
| | Child, Preschool | 25 | 2025 | 4162 | 1.120 |
Why?
| | Prenatal Exposure Delayed Effects | 5 | 2026 | 214 | 1.090 |
Why?
| | Esophageal Atresia | 3 | 2024 | 6 | 1.090 |
Why?
| | Infant, Small for Gestational Age | 4 | 2020 | 35 | 1.090 |
Why?
| | Occupational Diseases | 2 | 2026 | 82 | 1.080 |
Why?
| | Dietary Supplements | 4 | 2025 | 479 | 1.070 |
Why?
| | Cohort Studies | 13 | 2025 | 1557 | 1.020 |
Why?
| | Transposition of Great Vessels | 4 | 2024 | 26 | 1.010 |
Why?
| | Hernia, Umbilical | 4 | 2024 | 20 | 0.940 |
Why?
| | Adolescent | 27 | 2025 | 6907 | 0.930 |
Why?
| | Gestational Age | 8 | 2022 | 394 | 0.920 |
Why?
| | Tracheoesophageal Fistula | 2 | 2024 | 11 | 0.920 |
Why?
| | Fluorocarbons | 1 | 2025 | 65 | 0.890 |
Why?
| | Life Expectancy | 1 | 2025 | 35 | 0.890 |
Why?
| | Healthcare Disparities | 5 | 2025 | 312 | 0.870 |
Why?
| | Lamin Type A | 1 | 2024 | 5 | 0.860 |
Why?
| | Environmental Pollutants | 1 | 2025 | 110 | 0.850 |
Why?
| | Intellectual Disability | 2 | 2023 | 129 | 0.830 |
Why?
| | Esophageal Neoplasms | 1 | 2025 | 113 | 0.820 |
Why?
| | Public Health | 2 | 2024 | 231 | 0.810 |
Why?
| | Down Syndrome | 5 | 2025 | 95 | 0.810 |
Why?
| | Educational Status | 6 | 2025 | 229 | 0.800 |
Why?
| | Pregnancy Outcome | 5 | 2024 | 231 | 0.800 |
Why?
| | Policy | 1 | 2023 | 29 | 0.770 |
Why?
| | Prenatal Diagnosis | 6 | 2021 | 94 | 0.760 |
Why?
| | Proportional Hazards Models | 11 | 2026 | 445 | 0.750 |
Why?
| | DNA Methylation | 2 | 2024 | 592 | 0.750 |
Why?
| | Premature Birth | 4 | 2025 | 149 | 0.740 |
Why?
| | Delivery, Obstetric | 3 | 2020 | 109 | 0.740 |
Why?
| | Autistic Disorder | 2 | 2023 | 126 | 0.730 |
Why?
| | Insurance, Health | 1 | 2023 | 146 | 0.710 |
Why?
| | Length of Stay | 1 | 2025 | 684 | 0.710 |
Why?
| | Insurance Coverage | 1 | 2023 | 124 | 0.700 |
Why?
| | Genetic Variation | 3 | 2021 | 223 | 0.690 |
Why?
| | Placenta | 1 | 2022 | 146 | 0.680 |
Why?
| | Live Birth | 11 | 2022 | 24 | 0.670 |
Why?
| | Health Status Disparities | 3 | 2013 | 221 | 0.670 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2023 | 97 | 0.670 |
Why?
| | Hospitals, Teaching | 1 | 2020 | 52 | 0.660 |
Why?
| | Health Services Accessibility | 3 | 2023 | 477 | 0.660 |
Why?
| | Hospitalization | 1 | 2025 | 749 | 0.650 |
Why?
| | Tobacco, Smokeless | 1 | 2020 | 24 | 0.650 |
Why?
| | Abnormalities, Radiation-Induced | 1 | 2019 | 7 | 0.610 |
Why?
| | Hospitals | 1 | 2020 | 181 | 0.600 |
Why?
| | Nicotine | 1 | 2020 | 180 | 0.600 |
Why?
| | Middle Aged | 19 | 2026 | 13419 | 0.580 |
Why?
| | Tobacco Products | 1 | 2020 | 142 | 0.560 |
Why?
| | Spinal Dysraphism | 3 | 2025 | 39 | 0.540 |
Why?
| | Neoplasms | 3 | 2026 | 1334 | 0.520 |
Why?
| | Abnormalities, Drug-Induced | 1 | 2017 | 18 | 0.520 |
Why?
| | Heart Septal Defects | 1 | 2016 | 14 | 0.500 |
Why?
| | Texas | 9 | 2024 | 138 | 0.490 |
Why?
| | Maternal Age | 10 | 2024 | 42 | 0.470 |
Why?
| | Air Pollutants | 4 | 2021 | 75 | 0.470 |
Why?
| | Odds Ratio | 13 | 2026 | 567 | 0.470 |
Why?
| | Tetralogy of Fallot | 1 | 2016 | 83 | 0.470 |
Why?
| | Kaplan-Meier Estimate | 7 | 2024 | 487 | 0.460 |
Why?
| | Emergency Treatment | 1 | 2015 | 29 | 0.460 |
Why?
| | Developed Countries | 1 | 2015 | 17 | 0.460 |
Why?
| | Hysterectomy | 1 | 2015 | 91 | 0.450 |
Why?
| | Postpartum Hemorrhage | 1 | 2015 | 38 | 0.440 |
Why?
| | Limb Deformities, Congenital | 2 | 2025 | 15 | 0.440 |
Why?
| | Genome-Wide Association Study | 4 | 2023 | 184 | 0.430 |
Why?
| | Cause of Death | 5 | 2026 | 156 | 0.410 |
Why?
| | Thoracic Surgery | 1 | 2013 | 22 | 0.400 |
Why?
| | Neural Tube Defects | 2 | 2023 | 33 | 0.400 |
Why?
| | Western Australia | 4 | 2023 | 5 | 0.400 |
Why?
| | Birth Weight | 2 | 2010 | 119 | 0.390 |
Why?
| | Urinary Tract Infections | 2 | 2023 | 56 | 0.380 |
Why?
| | Infant, Premature, Diseases | 2 | 2017 | 97 | 0.380 |
Why?
| | Kidney Neoplasms | 2 | 2025 | 181 | 0.370 |
Why?
| | Exome | 4 | 2025 | 54 | 0.370 |
Why?
| | Cleft Palate | 2 | 2023 | 81 | 0.360 |
Why?
| | Liver Neoplasms | 3 | 2025 | 346 | 0.350 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2022 | 505 | 0.350 |
Why?
| | Australia | 3 | 2023 | 93 | 0.350 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 1723 | 0.340 |
Why?
| | Birth Certificates | 2 | 2021 | 26 | 0.340 |
Why?
| | Aged | 8 | 2026 | 10429 | 0.340 |
Why?
| | Anophthalmos | 2 | 2022 | 5 | 0.340 |
Why?
| | Florida | 5 | 2019 | 70 | 0.340 |
Why?
| | Microphthalmos | 2 | 2022 | 7 | 0.330 |
Why?
| | Comorbidity | 5 | 2025 | 638 | 0.330 |
Why?
| | Age Factors | 3 | 2025 | 1136 | 0.330 |
Why?
| | Air Pollution | 3 | 2019 | 49 | 0.330 |
Why?
| | Turner Syndrome | 2 | 2023 | 15 | 0.320 |
Why?
| | Incidence | 4 | 2025 | 1085 | 0.320 |
Why?
| | Risk Assessment | 7 | 2021 | 1368 | 0.310 |
Why?
| | Contraception | 3 | 2025 | 31 | 0.310 |
Why?
| | Ultrasonography, Prenatal | 3 | 2021 | 151 | 0.310 |
Why?
| | Survival Rate | 7 | 2024 | 949 | 0.300 |
Why?
| | Folic Acid | 3 | 2025 | 137 | 0.300 |
Why?
| | Micronesia | 2 | 2019 | 111 | 0.300 |
Why?
| | Counseling | 3 | 2025 | 141 | 0.290 |
Why?
| | Intestinal Atresia | 2 | 2026 | 5 | 0.280 |
Why?
| | Reproductive Health | 2 | 2025 | 9 | 0.280 |
Why?
| | Disinfection | 2 | 2024 | 11 | 0.260 |
Why?
| | Cardiology | 2 | 2023 | 106 | 0.260 |
Why?
| | Logistic Models | 7 | 2026 | 947 | 0.250 |
Why?
| | CpG Islands | 2 | 2024 | 114 | 0.250 |
Why?
| | Patient Acceptance of Health Care | 3 | 2025 | 379 | 0.250 |
Why?
| | Hepatoblastoma | 2 | 2023 | 5 | 0.240 |
Why?
| | Infant, Low Birth Weight | 2 | 2021 | 77 | 0.240 |
Why?
| | Genotype | 4 | 2023 | 563 | 0.240 |
Why?
| | Parturition | 3 | 2022 | 51 | 0.240 |
Why?
| | Inositol | 1 | 2025 | 19 | 0.240 |
Why?
| | Neuroblastoma | 2 | 2023 | 55 | 0.240 |
Why?
| | Fathers | 1 | 2026 | 27 | 0.240 |
Why?
| | Biliary Atresia | 2 | 2023 | 9 | 0.230 |
Why?
| | Medicaid | 2 | 2025 | 294 | 0.230 |
Why?
| | Mortality, Premature | 1 | 2025 | 12 | 0.230 |
Why?
| | Disinfectants | 2 | 2024 | 11 | 0.220 |
Why?
| | Aortic Coarctation | 2 | 2023 | 32 | 0.220 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 92 | 0.220 |
Why?
| | Water Purification | 1 | 2024 | 10 | 0.220 |
Why?
| | Drinking Water | 1 | 2024 | 12 | 0.220 |
Why?
| | Alleles | 3 | 2023 | 277 | 0.220 |
Why?
| | Water Pollutants, Chemical | 2 | 2024 | 54 | 0.210 |
Why?
| | Employment | 1 | 2025 | 94 | 0.210 |
Why?
| | Health Care Costs | 1 | 2025 | 178 | 0.210 |
Why?
| | Analysis of Variance | 2 | 2019 | 547 | 0.210 |
Why?
| | Time Factors | 4 | 2025 | 2991 | 0.210 |
Why?
| | Glaucoma | 1 | 2024 | 39 | 0.210 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2025 | 208 | 0.200 |
Why?
| | Household Products | 1 | 2023 | 2 | 0.200 |
Why?
| | Wilms Tumor | 1 | 2023 | 18 | 0.200 |
Why?
| | Thyroid Neoplasms | 1 | 2025 | 113 | 0.200 |
Why?
| | Socioeconomic Factors | 5 | 2023 | 623 | 0.200 |
Why?
| | Telemedicine | 2 | 2021 | 512 | 0.200 |
Why?
| | Pregnancy Complications | 2 | 2019 | 406 | 0.200 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2023 | 29 | 0.190 |
Why?
| | Mothers | 5 | 2023 | 269 | 0.190 |
Why?
| | Anencephaly | 1 | 2022 | 15 | 0.190 |
Why?
| | Fetal Death | 1 | 2022 | 22 | 0.190 |
Why?
| | Medically Uninsured | 1 | 2023 | 52 | 0.190 |
Why?
| | Autopsy | 1 | 2022 | 46 | 0.190 |
Why?
| | Common Cold | 1 | 2022 | 5 | 0.190 |
Why?
| | Cleft Lip | 1 | 2023 | 48 | 0.190 |
Why?
| | Bladder Exstrophy | 1 | 2022 | 5 | 0.190 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2022 | 45 | 0.190 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 212 | 0.180 |
Why?
| | Extreme Heat | 1 | 2021 | 3 | 0.180 |
Why?
| | Pyloric Stenosis, Hypertrophic | 1 | 2022 | 21 | 0.180 |
Why?
| | Birth Intervals | 1 | 2021 | 1 | 0.180 |
Why?
| | Hydrocephalus | 1 | 2022 | 46 | 0.180 |
Why?
| | Cluster Analysis | 1 | 2022 | 237 | 0.180 |
Why?
| | Cataract | 2 | 2019 | 44 | 0.180 |
Why?
| | Energy Intake | 2 | 2020 | 186 | 0.180 |
Why?
| | Nitrogen Dioxide | 2 | 2019 | 7 | 0.170 |
Why?
| | Electronic Health Records | 1 | 2024 | 287 | 0.170 |
Why?
| | Influenza, Human | 1 | 2022 | 88 | 0.170 |
Why?
| | Inheritance Patterns | 1 | 2021 | 22 | 0.170 |
Why?
| | Disabled Persons | 1 | 2021 | 73 | 0.170 |
Why?
| | Chromosome Disorders | 1 | 2021 | 32 | 0.170 |
Why?
| | Students | 1 | 2023 | 249 | 0.170 |
Why?
| | Term Birth | 1 | 2020 | 16 | 0.170 |
Why?
| | Quality of Life | 3 | 2021 | 902 | 0.160 |
Why?
| | Digestive System Abnormalities | 1 | 2019 | 6 | 0.160 |
Why?
| | Emotions | 1 | 2021 | 177 | 0.160 |
Why?
| | Schools | 1 | 2021 | 185 | 0.160 |
Why?
| | Truncus Arteriosus | 1 | 2019 | 8 | 0.150 |
Why?
| | Ozone | 1 | 2019 | 21 | 0.150 |
Why?
| | Pregnancy, Multiple | 1 | 2019 | 18 | 0.150 |
Why?
| | Radioactive Hazard Release | 1 | 2019 | 13 | 0.150 |
Why?
| | Health Services | 1 | 2020 | 71 | 0.150 |
Why?
| | Fetal Diseases | 1 | 2020 | 54 | 0.150 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 112 | 0.150 |
Why?
| | Urinalysis | 1 | 2019 | 33 | 0.150 |
Why?
| | Diacylglycerol Kinase | 1 | 2019 | 6 | 0.150 |
Why?
| | Gene-Environment Interaction | 1 | 2019 | 41 | 0.150 |
Why?
| | Dietary Fats | 1 | 2020 | 133 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2019 | 93 | 0.150 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 291 | 0.150 |
Why?
| | Cannabis | 1 | 2021 | 155 | 0.140 |
Why?
| | Emigrants and Immigrants | 1 | 2019 | 41 | 0.140 |
Why?
| | Abortion, Induced | 1 | 2018 | 20 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2020 | 219 | 0.140 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 12 | 0.140 |
Why?
| | Multivariate Analysis | 1 | 2019 | 598 | 0.140 |
Why?
| | Binge Drinking | 1 | 2018 | 25 | 0.140 |
Why?
| | Genotyping Techniques | 1 | 2017 | 19 | 0.130 |
Why?
| | Genetic Testing | 1 | 2018 | 130 | 0.130 |
Why?
| | Smoking Cessation | 1 | 2020 | 325 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2023 | 2318 | 0.130 |
Why?
| | Eating | 1 | 2017 | 159 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 130 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2017 | 280 | 0.120 |
Why?
| | Particulate Matter | 3 | 2021 | 66 | 0.120 |
Why?
| | Animals | 3 | 2026 | 13526 | 0.120 |
Why?
| | Peripartum Period | 1 | 2015 | 16 | 0.120 |
Why?
| | Confidence Intervals | 2 | 2016 | 158 | 0.110 |
Why?
| | Maternal Mortality | 1 | 2015 | 28 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1112 | 0.110 |
Why?
| | Residence Characteristics | 2 | 2014 | 163 | 0.110 |
Why?
| | Diet | 1 | 2019 | 610 | 0.110 |
Why?
| | Hypertension | 2 | 2014 | 554 | 0.110 |
Why?
| | Starvation | 1 | 2014 | 11 | 0.110 |
Why?
| | Sex Factors | 4 | 2017 | 747 | 0.100 |
Why?
| | Public Health Surveillance | 1 | 2013 | 18 | 0.100 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 630 | 0.100 |
Why?
| | Survival Analysis | 2 | 2014 | 659 | 0.100 |
Why?
| | Arizona | 2 | 2025 | 14 | 0.100 |
Why?
| | Heart Diseases | 2 | 2014 | 221 | 0.100 |
Why?
| | Trihalomethanes | 2 | 2024 | 2 | 0.100 |
Why?
| | Seroepidemiologic Studies | 2 | 2023 | 43 | 0.100 |
Why?
| | Research Design | 1 | 2015 | 373 | 0.100 |
Why?
| | Time-to-Treatment | 1 | 2013 | 81 | 0.090 |
Why?
| | Poverty | 1 | 2014 | 233 | 0.090 |
Why?
| | Pesticides | 1 | 2012 | 21 | 0.090 |
Why?
| | Respiratory Sounds | 1 | 2012 | 51 | 0.090 |
Why?
| | Acculturation | 1 | 2012 | 24 | 0.090 |
Why?
| | Cough | 1 | 2012 | 58 | 0.090 |
Why?
| | Thiazolidinediones | 1 | 2012 | 81 | 0.090 |
Why?
| | Referral and Consultation | 1 | 2014 | 299 | 0.090 |
Why?
| | Chlorophenols | 1 | 2011 | 1 | 0.090 |
Why?
| | Fractures, Bone | 1 | 2012 | 106 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2012 | 153 | 0.090 |
Why?
| | Health Services Needs and Demand | 2 | 2024 | 163 | 0.090 |
Why?
| | Anticonvulsants | 1 | 2012 | 133 | 0.090 |
Why?
| | Infant, Premature | 2 | 2017 | 331 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 227 | 0.080 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2010 | 58 | 0.080 |
Why?
| | South America | 2 | 2019 | 4 | 0.080 |
Why?
| | Epilepsy | 1 | 2012 | 189 | 0.080 |
Why?
| | Asia | 2 | 2019 | 24 | 0.080 |
Why?
| | Cognition | 2 | 2023 | 346 | 0.080 |
Why?
| | Europe | 2 | 2019 | 91 | 0.080 |
Why?
| | North America | 2 | 2019 | 75 | 0.080 |
Why?
| | Sex Distribution | 1 | 2009 | 140 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 182 | 0.080 |
Why?
| | Disease Susceptibility | 1 | 2009 | 96 | 0.080 |
Why?
| | Health Surveys | 2 | 2024 | 248 | 0.070 |
Why?
| | Fetal Development | 1 | 2009 | 50 | 0.070 |
Why?
| | Fetal Growth Retardation | 1 | 2009 | 35 | 0.070 |
Why?
| | Nutritional Status | 2 | 2020 | 148 | 0.070 |
Why?
| | Morbidity | 1 | 2009 | 132 | 0.070 |
Why?
| | Georgia | 3 | 2021 | 42 | 0.070 |
Why?
| | Abnormalities, Multiple | 2 | 2019 | 166 | 0.070 |
Why?
| | Heart Failure | 1 | 2012 | 531 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2021 | 1219 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 591 | 0.060 |
Why?
| | Intestine, Small | 1 | 2026 | 114 | 0.060 |
Why?
| | DNA Copy Number Variations | 1 | 2025 | 117 | 0.050 |
Why?
| | Water Supply | 1 | 2024 | 21 | 0.050 |
Why?
| | Genetic Diseases, Inborn | 1 | 2024 | 23 | 0.050 |
Why?
| | Analgesia, Epidural | 1 | 2004 | 28 | 0.050 |
Why?
| | Analgesia, Obstetrical | 1 | 2004 | 26 | 0.050 |
Why?
| | Prescription Drugs | 1 | 2024 | 40 | 0.050 |
Why?
| | Prejudice | 1 | 2004 | 37 | 0.050 |
Why?
| | Neural Crest | 1 | 2023 | 2 | 0.050 |
Why?
| | Cerebral Ventricles | 1 | 2023 | 27 | 0.050 |
Why?
| | Calpain | 1 | 2023 | 25 | 0.050 |
Why?
| | Homozygote | 1 | 2023 | 57 | 0.050 |
Why?
| | Workplace | 1 | 2004 | 98 | 0.050 |
Why?
| | Models, Genetic | 1 | 2023 | 169 | 0.050 |
Why?
| | Antibodies, Viral | 1 | 2023 | 109 | 0.050 |
Why?
| | Vitamins | 1 | 2022 | 64 | 0.050 |
Why?
| | Poisson Distribution | 1 | 2022 | 36 | 0.050 |
Why?
| | Syndrome | 1 | 2023 | 248 | 0.050 |
Why?
| | Aorta | 1 | 2023 | 172 | 0.050 |
Why?
| | Universities | 1 | 2023 | 186 | 0.050 |
Why?
| | Data Collection | 1 | 2023 | 288 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2022 | 110 | 0.040 |
Why?
| | Fever | 1 | 2022 | 112 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2004 | 282 | 0.040 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2021 | 6 | 0.040 |
Why?
| | Cities | 1 | 2021 | 32 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2021 | 145 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2023 | 333 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 774 | 0.040 |
Why?
| | Delivery of Health Care | 1 | 2023 | 317 | 0.040 |
Why?
| | Nutritive Value | 1 | 2020 | 30 | 0.040 |
Why?
| | Sulfur Dioxide | 1 | 2019 | 4 | 0.040 |
Why?
| | Abdominal Wall | 1 | 2019 | 13 | 0.040 |
Why?
| | Laboratories, Hospital | 1 | 2019 | 6 | 0.040 |
Why?
| | Parents | 1 | 2023 | 341 | 0.040 |
Why?
| | Amphetamines | 1 | 2019 | 26 | 0.040 |
Why?
| | Jamaica | 1 | 2019 | 7 | 0.040 |
Why?
| | Particle Size | 1 | 2019 | 76 | 0.040 |
Why?
| | Chromosome Aberrations | 1 | 2021 | 297 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2019 | 120 | 0.040 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 64 | 0.040 |
Why?
| | Mortality | 1 | 2019 | 98 | 0.040 |
Why?
| | Benzodiazepines | 1 | 2019 | 72 | 0.040 |
Why?
| | Ear | 1 | 2018 | 15 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 145 | 0.040 |
Why?
| | Fetus | 1 | 2020 | 191 | 0.040 |
Why?
| | Hematologic Neoplasms | 1 | 2020 | 101 | 0.040 |
Why?
| | Temperature | 1 | 2019 | 165 | 0.040 |
Why?
| | Eye Abnormalities | 1 | 2018 | 25 | 0.040 |
Why?
| | Mutation | 1 | 2024 | 1337 | 0.040 |
Why?
| | Methadone | 1 | 2019 | 187 | 0.030 |
Why?
| | Algorithms | 1 | 2022 | 667 | 0.030 |
Why?
| | Cocaine | 1 | 2019 | 168 | 0.030 |
Why?
| | Family | 1 | 2019 | 179 | 0.030 |
Why?
| | Lung Diseases | 1 | 2018 | 84 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 803 | 0.030 |
Why?
| | Diet Records | 1 | 2017 | 19 | 0.030 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 9 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 595 | 0.030 |
Why?
| | Vitamin B 6 | 1 | 2017 | 10 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 526 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 830 | 0.030 |
Why?
| | Food Analysis | 1 | 2017 | 27 | 0.030 |
Why?
| | Vitamin B 12 | 1 | 2017 | 27 | 0.030 |
Why?
| | Choline | 1 | 2017 | 64 | 0.030 |
Why?
| | Hypertension, Pulmonary | 1 | 2018 | 102 | 0.030 |
Why?
| | Buprenorphine | 1 | 2019 | 162 | 0.030 |
Why?
| | Colon | 1 | 2017 | 106 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 412 | 0.030 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 110 | 0.030 |
Why?
| | Quebec | 1 | 2016 | 12 | 0.030 |
Why?
| | Methionine | 1 | 2017 | 142 | 0.030 |
Why?
| | Decision Making | 1 | 2018 | 278 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2016 | 89 | 0.030 |
Why?
| | Body Mass Index | 1 | 2019 | 717 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 1003 | 0.030 |
Why?
| | Lung | 1 | 2018 | 481 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 867 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2015 | 49 | 0.030 |
Why?
| | Databases, Factual | 1 | 2017 | 742 | 0.030 |
Why?
| | China | 1 | 2014 | 135 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2017 | 1049 | 0.030 |
Why?
| | Oximetry | 1 | 2014 | 65 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 622 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2016 | 331 | 0.020 |
Why?
| | Nutrition Surveys | 1 | 2012 | 118 | 0.020 |
Why?
| | Biomedical Research | 1 | 2015 | 267 | 0.020 |
Why?
| | Critical Illness | 1 | 2014 | 316 | 0.020 |
Why?
| | Body Burden | 1 | 2011 | 11 | 0.020 |
Why?
| | Epidemiological Monitoring | 1 | 2011 | 15 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2011 | 47 | 0.020 |
Why?
| | Environmental Monitoring | 1 | 2011 | 75 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 2118 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3494 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2010 | 260 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2016 | 5595 | 0.010 |
Why?
| | Labor, Obstetric | 1 | 2004 | 38 | 0.010 |
Why?
| | Urban Health | 1 | 2004 | 31 | 0.010 |
Why?
|
|
Nembhard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|